Market Cap 568.26M
Revenue (ttm) 10.00M
Net Income (ttm) -130.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,306.40%
Debt to Equity Ratio -5.03
Volume 2,806,300
Avg Vol 2,249,232
Day's Range N/A - N/A
Shares Out 66.78M
Stochastic %K 22%
Beta 0.89
Analysts Strong Sell
Price Target $16.00

Company Profile

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma RAF/MEK, ERK mitogen activated pathway kinase pathway which is involved in cell proliferation, migration, transformation, and survival of tumor cells; and Defactinib, an oral small molecule inhibitor of FAK and proline-...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 292 4200
Address:
117 Kendrick Street, Suite 500, Needham, United States
Stoltz13
Stoltz13 Nov. 14 at 8:10 PM
$VSTM looks like we're ending the week with a bang.
1 · Reply
beeelaaal
beeelaaal Nov. 14 at 8:01 PM
$VSTM has cash in hand for 5 quarters , plus projected cash inflows . there is , was no need for any more offering .
1 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 5:55 PM
Hedge Alert Live - Protect Your Portfolio Contract: $VSTM $7.00 Put · NOV 21, 2025 Exp Entry Price: $0.10 - $0.20 Exit Price Target: $0.21 Profit Margin: +107% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
beeelaaal
beeelaaal Nov. 14 at 4:51 PM
$VSTM has the money and projected cash flows . a merger acquisition may be sonner than expected
2 · Reply
PencilNeckGeek
PencilNeckGeek Nov. 14 at 4:47 PM
$VSTM Holding up better than expected for now. Hopefully it continues
0 · Reply
Stoltz13
Stoltz13 Nov. 14 at 3:56 PM
$VSTM a good chance we go green today and if we do it's game on...
0 · Reply
sweddle
sweddle Nov. 14 at 3:53 PM
0 · Reply
Stoltz13
Stoltz13 Nov. 14 at 3:47 PM
$VSTM glad I pulled the trigger early, otherwise I would be chasing this...
0 · Reply
Marketismanipulated2
Marketismanipulated2 Nov. 14 at 3:40 PM
$VSTM bought 3k shares in premarket for $7.21 and sold them for $7.51. Also bought 60k dollars @ $7.31 to average down. If it dips under 10% down again I will avg down with another 100k can't let this buying opportunity pass now that funding shouldn't be a problem for quite a while.
1 · Reply
PencilNeckGeek
PencilNeckGeek Nov. 14 at 2:55 PM
$VSTM Exactly. Why the blatant public lie? And so recently too
1 · Reply
Latest News on VSTM
Verastem, Inc. (VSTM) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 10:16 AM EST - 10 days ago

Verastem, Inc. (VSTM) Q3 2025 Earnings Call Transcript


Verastem, Inc. (VSTM) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 8:55 PM EDT - 3 months ago

Verastem, Inc. (VSTM) Q2 2025 Earnings Call Transcript


Verastem: The Market Is Ignoring The Progress

Jul 16, 2025, 8:22 AM EDT - 4 months ago

Verastem: The Market Is Ignoring The Progress


U.S. FDA approves Verastem's cancer therapy

May 8, 2025, 12:23 PM EDT - 6 months ago

U.S. FDA approves Verastem's cancer therapy


Verastem Oncology Announces $75 million Private Placement

Apr 25, 2025, 9:00 AM EDT - 7 months ago

Verastem Oncology Announces $75 million Private Placement


Verastem Oncology Names Matthew E. Ros as Chief Operating Officer

Jan 15, 2025, 7:30 AM EST - 10 months ago

Verastem Oncology Names Matthew E. Ros as Chief Operating Officer


Verastem: Planning The PDUFA Run-Up

Jan 3, 2025, 11:56 AM EST - 11 months ago

Verastem: Planning The PDUFA Run-Up


Verastem: BLA Acceptance Puts Key Goals In Sight

Jan 2, 2025, 11:39 AM EST - 11 months ago

Verastem: BLA Acceptance Puts Key Goals In Sight


Verastem: Preparing For Upcoming Catalysts

Nov 27, 2024, 1:28 PM EST - 1 year ago

Verastem: Preparing For Upcoming Catalysts


Stoltz13
Stoltz13 Nov. 14 at 8:10 PM
$VSTM looks like we're ending the week with a bang.
1 · Reply
beeelaaal
beeelaaal Nov. 14 at 8:01 PM
$VSTM has cash in hand for 5 quarters , plus projected cash inflows . there is , was no need for any more offering .
1 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 5:55 PM
Hedge Alert Live - Protect Your Portfolio Contract: $VSTM $7.00 Put · NOV 21, 2025 Exp Entry Price: $0.10 - $0.20 Exit Price Target: $0.21 Profit Margin: +107% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
beeelaaal
beeelaaal Nov. 14 at 4:51 PM
$VSTM has the money and projected cash flows . a merger acquisition may be sonner than expected
2 · Reply
PencilNeckGeek
PencilNeckGeek Nov. 14 at 4:47 PM
$VSTM Holding up better than expected for now. Hopefully it continues
0 · Reply
Stoltz13
Stoltz13 Nov. 14 at 3:56 PM
$VSTM a good chance we go green today and if we do it's game on...
0 · Reply
sweddle
sweddle Nov. 14 at 3:53 PM
0 · Reply
Stoltz13
Stoltz13 Nov. 14 at 3:47 PM
$VSTM glad I pulled the trigger early, otherwise I would be chasing this...
0 · Reply
Marketismanipulated2
Marketismanipulated2 Nov. 14 at 3:40 PM
$VSTM bought 3k shares in premarket for $7.21 and sold them for $7.51. Also bought 60k dollars @ $7.31 to average down. If it dips under 10% down again I will avg down with another 100k can't let this buying opportunity pass now that funding shouldn't be a problem for quite a while.
1 · Reply
PencilNeckGeek
PencilNeckGeek Nov. 14 at 2:55 PM
$VSTM Exactly. Why the blatant public lie? And so recently too
1 · Reply
Huskerg
Huskerg Nov. 14 at 2:52 PM
$VSTM I've been here a long time and management has always raised at the absolute worst times relative to SP - pretty amazing really.
2 · Reply
Stoltz13
Stoltz13 Nov. 14 at 2:41 PM
$VSTM so a few long-term thinkers in early. I was waiting for a dip. But will probably make a decision around 10:30-11...
0 · Reply
boston_drew
boston_drew Nov. 14 at 2:31 PM
$VSTM surprised by offering and price seems like you could have waited for providing guidance to then seek investor money very poor timing but not fatal
0 · Reply
HoHoHoHum
HoHoHoHum Nov. 14 at 2:30 PM
$VSTM sometimes you have to grab what you can get in the premkt.
0 · Reply
ChesterKaita
ChesterKaita Nov. 14 at 2:26 PM
$VSTM We have sufficient capital to fund our ongoing commercial launch in the U.S. and continue advancing our current clinical development plans. Liars Going to post this everyday until they sell the company
0 · Reply
DonCorleone77
DonCorleone77 Nov. 14 at 2:20 PM
$VSTM Correction: The deal priced at $7.25, not $8.25. Jefferies, Guggenheim and Cantor Fitzgerald acted as joint book running managers for the offering.
0 · Reply
PencilNeckGeek
PencilNeckGeek Nov. 14 at 2:16 PM
$VSTM For weeks this was in the $9 range, yet they choose to dilute 20% lower
1 · Reply
PencilNeckGeek
PencilNeckGeek Nov. 14 at 2:13 PM
$VSTM Anyone trying to spin this as positive is full of shit
1 · Reply
Stoltz13
Stoltz13 Nov. 14 at 2:13 PM
$VSTM investing takes balls. You either have conviction and take opportunities to buy or you sit on the sidelines too scared to risk and never gaining.
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 14 at 2:03 PM
$VSTM (-10.6% pre) Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants https://ooc.bz/l/84616
0 · Reply
Vstm82103
Vstm82103 Nov. 14 at 1:50 PM
$VSTM @CrozrX Thank you, CrozrX. Your insight and research is always appreciated , and especially right now with yesterday’s dilutive new stock offering announcement. I can’t help but feel disappointed, angry & betrayed by Dan taking this action when just days before he said the opposite - that this was not even being considered. And to do it on the close of significant market down day. We long-term investors (7/9 years whatever it is) are so beat up and as I said feel BETRAYED by management. CrozrX , I hope you are right - it’s certainly seems plausible. A soon company announcement and/or explanation would be helpful. Maybe at next Wednesday’s Jeffery’s conference call🤔. THA
0 · Reply
ZacksResearch
ZacksResearch Nov. 14 at 1:30 PM
$TEM surges past industry with 20% rally — what's driving the momentum? 🚀 🔬 FDA clearance for xR IVD strengthening genomics foothold 🧪 New liquid biopsy xM for treatment monitoring 👥 Collaboration with $VSTM in pivotal clinical trials Discover the growth catalysts for Tempus AI here 👉 https://www.zacks.com/stock/news/2791072/tem-continues-to-strengthen-its-genomics-leadership-with-new-products?cid=sm-stocktwits-2-2791072-body-21086&ADID=SYND_STOCKTWITS_TWEET_2_2791072_BODY_21086
0 · Reply